查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1855865

2025年全球疾病登录软体市场报告

Disease Registry Software Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，疾病登记软体市场发展迅速，预计从2024年的13.9亿美元成长到2025年的15.5亿美元，复合年增长率达11.6%。预测期内的增长与慢性病负担加重、临床研究和试验的扩展、罕见患者病率上升、电子健康记录（EHR）的快速普及以及慢性病流行趋势的加剧密切相关。

预计未来几年疾病登记软体市场将快速成长，到2029年市场规模将达到23.8亿美元，年复合成长率（CAGR）为11.2%。预测期内的成长与以下因素密切相关：基于价值的医疗模式的日益普及、真实世界证据（RWE）的广泛应用、倡议医疗计划的推进、慢性病和文明病患病率的上升，以及对以患者为中心的医疗保健的日益重视。预测期内的关键趋势包括：医疗保健IT基础设施的进步、与远端医疗和远端监测的整合、与物联网（IoT）设备和穿戴式装置的连接、资料视觉化和仪表板的增强，以及区块链在资料安全和互通性的应用。

个人化医疗的日益普及预计将推动疾病登记软体市场的扩张。个人化医疗是一种根据个人的基因组成、生活方式和环境来客製化治疗和预防措施的方法。这项转变主要得益于基因组学的进步，基因组学能够准确地识别基因变异并开发客製化治疗方案。疾病登记软体在个人化医疗中发挥关键作用，它系统地收集和管理患者健康数据。这些系统简化了数据存取和分析，最终改善患者预后并推动精准医疗领域的发展。例如，根据个人化医疗联盟的报告，美国食品药物管理局)在 2023 年核准了26 种个人化新药，较 2022 年显着增加。因此，个人化医疗的日益普及正在推动对疾病登记软体的需求。

疾病登记软体市场的主要企业正致力于建立以患者为中心的登记系统，包括旨在追踪治疗结果并支援个人化医疗的数位化系统。数位化登记系统是系统性地收集、储存和管理病患健康资讯的电子平台，取代了传统的纸本方式。例如，2025年8月，美国心臟病学会启动了CONNECT-HCM登记系统，这是一个旨在提高对肥厚型心肌病（HCM，最常见的遗传性心血管疾病）的认识和管理的全国性数位化登记系统。该登记系统支援跨多个医疗机构的患者直接註册，从而弥补了诊断和治疗方面的不足。该登记系统透过Hugo Connect平台将登记资料与电子健康记录连接起来，使研究人员能够追踪患者的症状、影像学结果、治疗方案和治疗结果随时间的变化。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球疾病登记软体：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球疾病登录软体市场：成长率分析
  • 全球疾病登录软体市场表现：规模与成长，2019-2024年
  • 全球疾病登记软体市场预测：规模与成长，2024-2029年，2034年预测
  • 全球疾病登录软体：潜在市场规模 (TAM)

第六章 市场细分

  • 全球疾病登记软体市场按类型划分，实际数据及预测数据（2019-2024年、2024-2029年预测、2034年预测）
  • 独立版
  • 一体化
  • 全球疾病登记软体市场（依资料库）、实际资料及预测（2019-2024年、2024-2029年预测、2034年预测）
  • 公共
  • 商业的
  • 全球疾病登记软体市场依部署模式划分，实际数据及预测（2019-2024年、2024-2029年预测、2034年预测）。
  • 本地部署
  • 云端基础的
  • 全球疾病登录软体市场：依最终用户划分，实际数据和预测数据，2019-2024年、2024-2029年预测数据、2034年预测数据
  • 医院
  • 政府机构
  • 研究中心
  • 製药公司
  • 其他最终用户
  • 全球疾病登记软体市场：依独立模式、类型、实际值及预测值分類的细分市场，2019-2024年、2024-2029年预测值、2034年预测值
  • 病人登记软体
  • 人口健康登记软体
  • 研究註册软体
  • 客製化/单一疾病登记软体
  • 全球疾病登录软体市场：依整合类型细分，实际资料及预测资料（2019-2024年、2024-2029年预测、2034年预测）。
  • 电子健康记录(EHR) 整合註册软体
  • 诊所管理系统 - 整合註册软体
  • 临床决策支援（CDS）- 整合註册软体
  • 交换医疗资讯（HIE）- 整合註册软体

第七章 区域和国家分析

  • 全球疾病登录软体市场：依地区划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 全球疾病登记软体市场：按国家/地区划分，实际值和预测值，2019-2024 年、2024-2029 年预测值、2034 年预测值

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 疾病登记软体市场：竞争格局
  • 疾病登记软体市场：公司概况
    • Optum Inc. Overview, Products and Services, Strategy and Financial Analysis
    • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Epic Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Premier Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • MRO Corp.
  • ImageTrend Inc.
  • Anju Software Inc.
  • BayaTree Inc.
  • Medrio Inc.
  • ArborMetrix Inc.
  • Cedaron Medical Inc.
  • Evado Pty. Ltd.
  • OpenClinica LLC
  • Dacima Software Inc.
  • Global Vision Technologies Inc.
  • Ordinal Data Inc.
  • Healthmonix LLC
  • Axis Clinical Software Inc.
  • Vanderbilt University

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年疾病登录软体市场：提供新机会的国家
  • 2029年疾病登记软体市场：提供新机会的细分市场
  • 2029年疾病登录软体市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38514

Disease registry software is a dedicated digital platform designed to gather, organize, and manage patient information related to specific diseases or medical conditions. It enables healthcare providers, researchers, and policymakers to track disease trends, evaluate treatment outcomes, maintain regulatory compliance, and support clinical decisions to enhance patient care and overall population health.

The primary categories of disease registry software are standalone and integrated. Standalone systems operate independently to collect, manage, and analyze disease-specific patient data without relying on hospital or clinic infrastructure. These databases can be public or commercial, with deployment options including on-premises and cloud-based models, and they serve hospitals, government agencies, research institutions, pharmaceutical companies, and other users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The disease registry software market research report is one of a series of new reports from The Business Research Company that provides disease registry software market statistics, including the disease registry software industry global market size, regional shares, competitors with the disease registry software market share, detailed disease registry software market segments, market trends, and opportunities, and any further data you may need to thrive in the disease registry software industry. This disease registry software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The disease registry software market size has grown rapidly in recent years. It will grow from $1.39 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be linked to the increasing burden of chronic diseases, expansion of clinical research and trials, rising prevalence of rare diseases, rapid adoption of electronic health records (EHRs), and the widespread occurrence of chronic conditions.

The disease registry software market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be linked to the expanding adoption of value-based care models, increased use of real-world evidence (RWE), growth of precision medicine initiatives, rising incidence of chronic and lifestyle-related diseases, and stronger emphasis on patient-centered healthcare. Key trends during the forecast period include advancements in healthcare IT infrastructure, integration with telehealth and remote monitoring, connection with internet of things (IoT) devices and wearables, enhanced data visualization and dashboards, and use of blockchain for data security and interoperability.

The growing adoption of personalized medicine is expected to drive the expansion of the disease registry software market. Personalized medicine is an approach that customizes treatment and prevention based on an individual's genetic makeup, lifestyle, and environment. This shift is largely driven by advancements in genomics, which allow for the precise identification of genetic variations and the development of tailored treatments. Disease registry software plays a crucial role in personalized medicine by systematically gathering and managing patient health data, enabling the creation of personalized treatment plans and supporting improved clinical decision-making. These systems streamline access to and analysis of data, ultimately enhancing patient outcomes and advancing the field of precision healthcare. For instance, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a substantial increase from 2022. As a result, the growing adoption of personalized medicine is fueling the demand for disease registry software.

Leading companies in the disease registry software market are focusing on creating patient-centric registries, such as digital systems designed to track outcomes and support personalized care. Digital registries are electronic platforms that systematically collect, store, and manage patient health information, replacing traditional paper-based methods. For example, in August 2025, the American College of Cardiology launched the CONNECT-HCM Registry, a nationwide digital registry aimed at improving the understanding and management of hypertrophic cardiomyopathy (HCM), the most common genetic cardiovascular condition. This registry allows for direct patient enrollment across multiple centers, addressing gaps in diagnosis and care. It links registry data with electronic health records via Arboretum's Hugo Connect platform, enabling researchers to track symptoms, imaging results, treatments, and outcomes over time.

In November 2023, Health Catalyst Inc., a U.S.-based healthcare analytics company, acquired Electronic Registry Systems Inc. (ERS) to enhance its oncology registry capabilities. With this acquisition, Health Catalyst integrates ERS's cancer data management expertise into its suite of tech-enabled managed services, improving data abstraction, reporting, and analytics for healthcare organizations. ERS is a U.S.-based company specializing in cancer registry software and services.

Major players in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., and Vanderbilt University.

North America was the largest region in the disease registry software market in 2024. The regions covered in disease registry software report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the disease registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The disease registry software market includes revenues earned by entities through patient data management, real-time data collection, integration with electronic health records, analytics and reporting, clinical research support, chronic disease management, and public health surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Disease Registry Software Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on disease registry software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for disease registry software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The disease registry software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Standalone; Integrated
  • 2) By Database: Public; Commercial
  • 3) By Deployment Mode: On-Premises; Cloud-Based
  • 4) By End-User: Hospitals; Government Organizations; Research Centers; Pharmaceutical Companies; Other End Users
  • Subsegments:
  • 1) By Standalone: Patient Registry Software; Population Health Registry Software; Research Registry Software; Custom Or Single-Disease Registry Software
  • 2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software; Practice Management System-Integrated Registry Software; Clinical Decision Support (CDS)-Integrated Registry Software; Health Information Exchange (HIE)-Integrated Registry Software
  • Companies Mentioned: Optum Inc.; IQVIA Holdings Inc.; Syneos Health Inc.; Epic Systems Corporation; Premier Inc.; MRO Corp.; ImageTrend Inc.; Anju Software Inc.; BayaTree Inc.; Medrio Inc.; ArborMetrix Inc.; Cedaron Medical Inc.; Evado Pty. Ltd.; OpenClinica LLC; Dacima Software Inc.; Global Vision Technologies Inc.; Ordinal Data Inc.; Healthmonix LLC; Axis Clinical Software Inc.; Vanderbilt University
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Disease Registry Software Market Characteristics

3. Disease Registry Software Market Trends And Strategies

4. Disease Registry Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Disease Registry Software Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Disease Registry Software PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Disease Registry Software Market Growth Rate Analysis
  • 5.4. Global Disease Registry Software Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Disease Registry Software Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Disease Registry Software Total Addressable Market (TAM)

6. Disease Registry Software Market Segmentation

  • 6.1. Global Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standalone
  • Integrated
  • 6.2. Global Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Public
  • Commercial
  • 6.3. Global Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.4. Global Disease Registry Software Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Government Organizations
  • Research Centers
  • Pharmaceutical Companies
  • Other End Users
  • 6.5. Global Disease Registry Software Market, Sub-Segmentation Of Standalone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient Registry Software
  • Population Health Registry Software
  • Research Registry Software
  • Custom/Single-Disease Registry Software
  • 6.6. Global Disease Registry Software Market, Sub-Segmentation Of Integrated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic Health Record (EHR)-Integrated Registry Software
  • Practice Management System-Integrated Registry Software
  • Clinical Decision Support (CDS)-Integrated Registry Software
  • Health Information Exchange (HIE)-Integrated Registry Software

7. Disease Registry Software Market Regional And Country Analysis

  • 7.1. Global Disease Registry Software Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Disease Registry Software Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Disease Registry Software Market

  • 8.1. Asia-Pacific Disease Registry Software Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Disease Registry Software Market

  • 9.1. China Disease Registry Software Market Overview
  • 9.2. China Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Disease Registry Software Market

  • 10.1. India Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Disease Registry Software Market

  • 11.1. Japan Disease Registry Software Market Overview
  • 11.2. Japan Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Disease Registry Software Market

  • 12.1. Australia Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Disease Registry Software Market

  • 13.1. Indonesia Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Disease Registry Software Market

  • 14.1. South Korea Disease Registry Software Market Overview
  • 14.2. South Korea Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Disease Registry Software Market

  • 15.1. Western Europe Disease Registry Software Market Overview
  • 15.2. Western Europe Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Disease Registry Software Market

  • 16.1. UK Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Disease Registry Software Market

  • 17.1. Germany Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Disease Registry Software Market

  • 18.1. France Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Disease Registry Software Market

  • 19.1. Italy Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Disease Registry Software Market

  • 20.1. Spain Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Disease Registry Software Market

  • 21.1. Eastern Europe Disease Registry Software Market Overview
  • 21.2. Eastern Europe Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Disease Registry Software Market

  • 22.1. Russia Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Disease Registry Software Market

  • 23.1. North America Disease Registry Software Market Overview
  • 23.2. North America Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Disease Registry Software Market

  • 24.1. USA Disease Registry Software Market Overview
  • 24.2. USA Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Disease Registry Software Market

  • 25.1. Canada Disease Registry Software Market Overview
  • 25.2. Canada Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Disease Registry Software Market

  • 26.1. South America Disease Registry Software Market Overview
  • 26.2. South America Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Disease Registry Software Market

  • 27.1. Brazil Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Disease Registry Software Market

  • 28.1. Middle East Disease Registry Software Market Overview
  • 28.2. Middle East Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Disease Registry Software Market

  • 29.1. Africa Disease Registry Software Market Overview
  • 29.2. Africa Disease Registry Software Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Disease Registry Software Market, Segmentation By Database, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Disease Registry Software Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Disease Registry Software Market Competitive Landscape And Company Profiles

  • 30.1. Disease Registry Software Market Competitive Landscape
  • 30.2. Disease Registry Software Market Company Profiles
    • 30.2.1. Optum Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Epic Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Premier Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Disease Registry Software Market Other Major And Innovative Companies

  • 31.1. MRO Corp.
  • 31.2. ImageTrend Inc.
  • 31.3. Anju Software Inc.
  • 31.4. BayaTree Inc.
  • 31.5. Medrio Inc.
  • 31.6. ArborMetrix Inc.
  • 31.7. Cedaron Medical Inc.
  • 31.8. Evado Pty. Ltd.
  • 31.9. OpenClinica LLC
  • 31.10. Dacima Software Inc.
  • 31.11. Global Vision Technologies Inc.
  • 31.12. Ordinal Data Inc.
  • 31.13. Healthmonix LLC
  • 31.14. Axis Clinical Software Inc.
  • 31.15. Vanderbilt University

32. Global Disease Registry Software Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Disease Registry Software Market

34. Recent Developments In The Disease Registry Software Market

35. Disease Registry Software Market High Potential Countries, Segments and Strategies

  • 35.1 Disease Registry Software Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Disease Registry Software Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Disease Registry Software Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer